ELV Q1 2026 Earnings Strong EPS Beat Driven by Operational Excellence MED Q1 2026 Earnings EPS Surprises with Smaller Loss Than Expected IMVT Q1 2026 Earnings EPS Misses Estimates Stock Slightly Positive Amid Development Progress Vaxcyte PCVX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline RAIL Q1 2026 Earnings WiderthanExpected Loss Sends Shares Lower XGN Q1 2026 Earnings EPS Beat Highlights Cost Discipline Amid Revenue Uncertainty